Company Filing History:
2 out of 1,746 
2 out of 281 
1 out of 99 
Years Active: 2020-2024
Title: Innovations by Nicolas Tricaud
Introduction
Nicolas Tricaud is a notable inventor based in Montpellier, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of peripheral demyelinating diseases. With a total of 3 patents to his name, Tricaud's work is recognized for its innovative approaches to medical challenges.
Latest Patents
Tricaud's latest patents include groundbreaking methods and pharmaceutical compositions aimed at treating peripheral demyelinating diseases. One of his inventions focuses on a method of treating such diseases by administering a therapeutically effective amount of an inhibitor of VDAC1 activity or expression. Another significant patent involves methods and pharmaceutical compositions for expressing a polynucleotide of interest in the peripheral nervous system. This invention details a method for selectively expressing a polynucleotide in the peripheral nervous system by transducing a peripheral nerve with an AVV9 vector containing the polynucleotide.
Career Highlights
Throughout his career, Nicolas Tricaud has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Montpellier. His research has contributed to advancements in understanding and treating neurological conditions, showcasing his commitment to improving patient outcomes.
Collaborations
Tricaud has collaborated with notable colleagues, including Sergio Gonzalez and Patrick Aubourg. These partnerships have further enriched his research and development efforts in the pharmaceutical field.
Conclusion
Nicolas Tricaud's innovative work in the treatment of peripheral demyelinating diseases highlights his role as a significant contributor to medical science. His patents reflect a dedication to advancing therapeutic methods and improving the lives of those affected by such conditions.